Found: 13
Select item for more details and to access through your institution.
Death-associated protein kinase: A molecule with functional antagonistic duality and a potential role in inflammatory bowel disease (Review).
- Published in:
- International Journal of Oncology, 2015, v. 47, n. 1, p. 5, doi. 10.3892/ijo.2015.2998
- By:
- Publication type:
- Article
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2055, doi. 10.3390/ijms24032055
- By:
- Publication type:
- Article
Spectrum of Tendon Pathologies: Triggers, Trails and End-State.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 3, p. 844, doi. 10.3390/ijms21030844
- By:
- Publication type:
- Article
Carborane‐Based Analogues of 5‐Lipoxygenase Inhibitors Co‐inhibit Heat Shock Protein 90 in HCT116 Cells.
- Published in:
- ChemMedChem, 2019, v. 14, n. 2, p. 255, doi. 10.1002/cmdc.201800651
- By:
- Publication type:
- Article
Multiphoton Microscopy Reveals DAPK1-Dependent Extracellular Matrix Remodeling in a Chorioallantoic Membrane (CAM) Model.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2364, doi. 10.3390/cancers14102364
- By:
- Publication type:
- Article
Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 6, p. N.PAG, doi. 10.1038/s41419-019-1611-4
- By:
- Publication type:
- Article
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03177-7
- By:
- Publication type:
- Article
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02394-2
- By:
- Publication type:
- Article
Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27 KIP1 Regulation.
- Published in:
- Medicina (1010660X), 2024, v. 60, n. 7, p. 1160, doi. 10.3390/medicina60071160
- By:
- Publication type:
- Article